We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Greiner Bio-One

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
14 Jul 2020 - 14 Jul 2020
Virtual Venue
15 Jul 2020 - 19 Jul 2020
Virtual Venue

OpenSight Augmented Reality System for Microsoft HoloLens Cleared by FDA

By HospiMedica International staff writers
Posted on 12 Nov 2018
Print article
Image: The OpenSight Augmented Reality System (Photo courtesy of Novarad).
Image: The OpenSight Augmented Reality System (Photo courtesy of Novarad).
The FDA has granted 510(k) clearance to the OpenSight Augmented Reality System, making it the first AR medical solution for Microsoft HoloLens to be cleared for use in pre-operative surgical planning. Developed by Novarad (American Fork, UT, USA), a provider of specialized enterprise imaging and workflow solutions, OpenSight renders 2D, 3D and 4D images of patients interactively, while accurately overlaying them directly onto the patient’s body.

OpenSight utilizes the Microsoft HoloLens headset that not only allows doctors to see the 3D patient images in AR, but also to see the patient (reality) at the same time, allowing them to more accurately plan surgery. OpenSight AR provides a better understanding of anatomic relationships because the images are co-localized to the patient. Pre-operative planning with OpenSight makes it possible to highlight relevant anatomy and critical structures to avoid, as well as position virtual tools and guidance systems to more accurately plan a surgical approach.

“This is transformative technology that will unite preoperative imaging with augmented reality to improve the precision, speed and safety of medical procedures,” said Dr. Wendell Gibby, Novarad CEO and co-creator of OpenSight. “This internal visualization can now be achieved without the surgeon ever making an incision, improving outcomes in a world of more precise medicine.”

Print article


Copyright © 2000-2020 Globetech Media. All rights reserved.